Transgene's Combined General Meeting of May 25, 2022

Regulatory News: The Combined Ordinary and Extraordinary General Meeting of Transgene's (Paris:TNG) shareholders was held today (May 25, 2022) at 10:00 a.m. at the Company's headquarters (400 boulevard

Related Keywords

Milan ,Lombardia ,Italy ,United States ,Illkirch Graffenstaden ,Alsace ,France ,Andernach ,Rheinland Pfalz ,Germany ,French ,Lucie Larguier ,Sandrine Flory ,Ben Brahim ,Alessandro Riva ,Marie Landel ,Sylvie Berrebi ,Laurence Espinasse ,Philippe Archinard ,Transgene Euronext ,Centre Sud Montpellier ,European Society Of Medical Oncology ,Twitter ,European Commission Conticanet ,Claude Bernard University In Lyon ,Astrazeneca ,French National Cancer Institute ,Scientific Panel For Health ,French National Academy Of Medicine ,European Organization For Research ,Cell Gene Therapy At Gilead Sciences ,Global Head Of Oncology Development ,Ichnos Sciences ,Ernst Young ,Corporate Communications ,Affairs At Novartis Pharmaceuticals ,Life Sciences ,French Sarcoma Group ,University Of Milan ,Regulatory News ,Combined Ordinary ,Extraordinary General Meeting ,Andernach Parc ,Hedi Ben Brahim ,Combined General Meeting ,Jean Yves Blay ,Board Members ,Statutory Auditor ,Chief Executive Officer ,Hedi Ben ,Honorary Chairman ,Investors General ,Intima Bioscience ,Executive Vice President ,Global Head ,Oncology Therapeutics ,Cell Gene Therapy ,Gilead Sciences ,Kite Pharma ,Oncology Development ,Medical Affairs ,Novartis Oncology ,Yves Blay ,Medical Oncology ,General Director ,Claude Bernard University ,French National Cancer ,European Organization ,French Sarcoma ,European Society ,Scientific Panel ,European Commission ,French National Academy ,Legal Director ,Mission Director ,Professional Lawyer ,Business Law ,Centre Sud ,Artificial Intelligence ,Risk Factors ,Universal Registration Document ,Transgene ,Combined ,Eneral ,Meeting ,022 ,